| Financial Year |
March 31 2023 |
| Monetary Funds |
1,111,452,478.10 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
85,330,684.22 |
| Accounts Receivable |
917,008,098.88 |
| Advances to Suppliers |
79,546,319.07 |
| Other Receivables |
33,408,467.66 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
415,411,708.13 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
32,353,126.90 |
| Total Current Assets |
2,718,313,906.96 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
28,758,843.74 |
| Investment Properties |
-- |
| Fixed Assetes |
1,146,899,695.76 |
| Under-construction Projects |
58,332,510.95 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
120,918,115.93 |
| R&D expenses |
-- |
| Goodwill |
61,008,277.17 |
| Long-Term Deferred and Prepaid Expenses |
110,202,782.97 |
| Deferred Income Tax Assets |
48,332,543.32 |
| Other Non-Current Assets |
80,405,315.25 |
| Sub-Total of Non-Current Assets |
1,924,463,382.08 |
| Total Assets |
4,642,777,289.04 |
| Short-Term Loans |
516,334,983.94 |
| Trading Financial liabilities |
-- |
| Notes Payable |
4,227,724.50 |
| Accounts Payable |
337,624,524.01 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
48,903,232.39 |
| Taxes Payable |
15,925,177.98 |
| Interest Payable |
-- |
| Dividend Payable |
4,065,000.00 |
| Other payables |
35,002,238.14 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
129,400,237.61 |
| Other Current Liabilities |
13,629,209.05 |
| Sub-Total of Current Liabilities |
1,365,277,860.44 |
| Long-term Loans |
218,936,000.04 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
2,633,435.97 |
| Deferred Income Tax Liabilities |
16,764,900.74 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
484,970,463.01 |
| Total Liabilities |
1,850,248,323.45 |
| Paid-In Capital(Or Share Stock) |
391,190,620.00 |
| Capital Surplus |
1,064,941,416.56 |
| Surplus Reserve |
50,287,398.88 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
886,704,306.43 |
| Minority Stockholder's Interest |
399,405,223.72 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,393,123,741.87 |
| Owner's Equity（Stockholder's Equity） |
2,792,528,965.59 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,642,777,289.04 |
